Cargando…

Pharmacological CCR1 blockade limits infarct size and preserves cardiac function in a chronic model of myocardial ischemia/reperfusion

Detalles Bibliográficos
Autores principales:	Van de Sandt, A, Zander, S, Becher, S, Ercan, R, Quast, C, Ohlig, J, Lauer, T, Rassaf, T, Kelm, M, Merx, MW
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061634/ http://dx.doi.org/10.1186/cc9424

Ejemplares similares

Neuronal NOS-inhibition in the setting of septic cardiomyopathy
por: Sandt, A van de, et al.
Publicado: (2010)

Circulating NOS3 Modulates Left Ventricular Remodeling following Reperfused Myocardial Infarction
por: Gorressen, Simone, et al.
Publicado: (2015)

Endothelial nitric oxide synthase deficiency and inducible nitric oxide synthase inhibition in the setting of septic cardiomyopathy
por: Sandt, A Van de, et al.
Publicado: (2009)

Ccr1 deficiency reduces inflammatory remodelling and preserves left ventricular function after myocardial infarction
por: Liehn, E A, et al.
Publicado: (2008)

Depletion of circulating blood NOS3 increases severity of myocardial infarction and left ventricular dysfunction
por: Merx, Marc W., et al.
Publicado: (2013)

Endothelial NOS (NOS3) impairs myocardial function in developing sepsis
por: van de Sandt, Annette M., et al.
Publicado: (2013)

Blockade of CCR3 retains the neutrophils, preserving their survival during healing after myocardial infarction
por: Curaj, Adelina, et al.
Publicado: (2015)

Cardioprotective effects of pharmacological blockade of the mitochondrial calcium uniporter on myocardial ischemia-reperfusion injury
por: Menezes-Rodrigues, Francisco Sandro, et al.
Publicado: (2020)

Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation
por: Rassaf, T, et al.
Publicado: (2010)

Cardiac ischemia and reperfusion in mice: a comprehensive hemodynamic, electrocardiographic and electrophysiological characterization
por: Clasen, Lukas, et al.
Publicado: (2023)

Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis
por: Lebre, Maria C., et al.
Publicado: (2011)

Pharmacology of Catechins in Ischemia-Reperfusion Injury of the Heart
por: Ferenczyová, Kristína, et al.
Publicado: (2021)

Cardiogenic shock in the Aachen Digital Myocardial Infarction Registry
por: Kersten, A, et al.
Publicado: (2007)

Ischemia-Reperfusion Injuries Assessment during Pancreas Preservation
por: Prudhomme, Thomas, et al.
Publicado: (2021)

Preservation of Mitochondrial Health in Liver Ischemia/Reperfusion Injury
por: Machado, Ivo F., et al.
Publicado: (2023)

Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
por: Adachi, Takaomi, et al.
Publicado: (2013)

The Expanding Therapeutic Perspective of CCR5 Blockade
por: Vangelista, Luca, et al.
Publicado: (2018)

Expression of CCL2 and CCR2 in the hippocampus and the interventional roles of propofol in rat cerebral ischemia/reperfusion
por: GUO, YONG-QING, et al.
Publicado: (2014)

Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
por: Soares, Ricardo O. S., et al.
Publicado: (2019)

Blockade of Wnt Secretion Attenuates Myocardial Ischemia–Reperfusion Injury by Modulating the Inflammatory Response
por: Meyer, Ingmar Sören, et al.
Publicado: (2022)

Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury
por: Jungraithmayr, Wolfgang
Publicado: (2020)

Preservation solutions for attenuation of ischemia–reperfusion injury in vascularized composite allotransplantation
por: Datta, Shaishav, et al.
Publicado: (2021)

A Potential Route to Reduce Ischemia/Reperfusion Injury in Organ Preservation
por: Micó-Carnero, Marc, et al.
Publicado: (2022)

Hydrogen gas and preservation of intestinal stem cells in mesenteric ischemia and reperfusion
por: Yamamoto, Ryo, et al.
Publicado: (2022)

Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury
por: Hałucha, Kornela, et al.
Publicado: (2021)

Activation of CCL21-GPR174/CCR7 on cardiac fibroblasts underlies myocardial ischemia/reperfusion injury
por: Meng, Xiao-Wen, et al.
Publicado: (2022)

Pharmacological Benefits and Risk of Using Hormones in Organ Perfusion and Preservation Solutions in the Aspect of Minimizing Hepatic Ischemia-Reperfusion Injury during Storage
por: Ostróżka-Cieślik, Aneta, et al.
Publicado: (2019)

Innovative Pharmacological/Therapeutic Approaches against Hepatic Ischemia/Reperfusion Injury
por: Vairetti, Mariapia, et al.
Publicado: (2015)

Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury
por: Zhu, Ting, et al.
Publicado: (2023)

Blockade of Transient Receptor Potential Vanilloid 4 Enhances Antioxidation after Myocardial Ischemia/Reperfusion
por: Wu, Qiongfeng, et al.
Publicado: (2019)

A practical approach to remote ischemic preconditioning and ischemic preconditioning against myocardial ischemia/reperfusion injury
por: Totzeck, Matthias, et al.
Publicado: (2016)

Calenduloside E alleviates cerebral ischemia/reperfusion injury by preserving mitochondrial function
por: Li, Jianxiong, et al.
Publicado: (2022)

Oxygen-carrying sequential preservation mitigates liver grafts ischemia-reperfusion injury
por: Li, Jianbo, et al.
Publicado: (2022)

Melatonin Preserves Fluidity in Cell and Mitochondrial Membranes against Hepatic Ischemia–Reperfusion
por: Esteban-Zubero, Eduardo, et al.
Publicado: (2023)

Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion
por: Wu, Xun, et al.
Publicado: (2021)

Pharmacological postconditioning with diazoxide attenuates ischemia/reperfusion-induced injury in rat liver
por: TIAN, Y.S., et al.
Publicado: (2013)

Strategies for Pharmacological Organoprotection during Extracorporeal Circulation Targeting Ischemia-Reperfusion Injury
por: Salameh, Aida, et al.
Publicado: (2015)

Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
por: Ibarrola, Jaime, et al.
Publicado: (2019)

Pharmacological Inhibition of S-Nitrosoglutathione Reductase Reduces Cardiac Damage Induced by Ischemia–Reperfusion
por: Castillo, Oscar Arriagada, et al.
Publicado: (2021)

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury
por: Magga, Johanna, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6rmn7509ob8871ultouqt5ghsf